AI Labs
OpenAI acquires Orchestra Bio
OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
You're reading a preview. The full article is published by OpenAI on their website.
Read the full story on OpenAI

